<DOC>
	<DOCNO>NCT02444728</DOCNO>
	<brief_summary>Treating severe thrombocytopenia challenge management systemic lupus erythematosus . Although rheumatologist follow rule real practice , evidence support current treatment algorithm . The purpose study compare complete remission rate partial remission rate cyclophosphamide hydroxychloroquine treat severe thrombocytopenia Chinese SLE patient .</brief_summary>
	<brief_title>Cyclophosphamide Hydroxychloroquine Thrombocytopenia SLE</brief_title>
	<detailed_description>This prospective , randomize , open-label , multi-center clinical trial . The aim study test efficacy GC ( gluco-corticosteroid ) +HCQ ( hydroxychloroquine ) GC ( glucocorticosteroid ) +CTX ( cyclophosphamide ) sequential AZA ( azathioprine ) induction maintenance therapy severe thrombocytopenia SLE patient .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>1 . Patients fulfilled 1997 ACR modify SLICC classification criterion SLE； 2 . New onset thrombocytopenia : platelet count &lt; 30X109/L ( routine test citric acid anticoagulated blood count test ) within 3 month 1 . Thrombocytopenia cause reason , include drugs； 2 . Positive active HAV ( hepatitis A virus ) /HBV ( hepatitis B virus ) infection 3 . Active HIV ( human immunodeficiency virus ) HCV ( hepatitis C virus ) infection ; 4 . Active HP ( Helicopter pylori ) infection ; 5 . Severe liver kidney dysfunction； 6 . Severe neuropsychiatric lupus； 7 . No response high dose steroid and/or cyclophosphamide 1 month prior study enrollment； 8 . Uncontrolled diabetes hypertension entry 9 . Active GI bleed 3 month entry 10 . Intolerant HCQ past treatment history； 11 . Severe bone marrow suppression liver damage cause cyclophosphamide past history； 12 . Active infection , include bacteria , virus , fungi , mycobacteria 13 . Allergy study medication 14 . Confirmed TTP ( thrombolic thrombocytopenic purpura ) CAPS ( catastrophic antiphosphilipid syndrome ) 15 . Platelet count le 20X109/L active bleed 16 . Myelodysplastic disease 17 . Patients heart lung function impairment 18. thiopurine Smethyltransferase ( TPMT ) gene positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>thrombocytopenia</keyword>
	<keyword>systemic lupus erythematosus</keyword>
	<keyword>hydroxychloroquine</keyword>
	<keyword>cyclophosphamide</keyword>
	<keyword>remission</keyword>
</DOC>